Repligen Corporation
Building 1
Suite 100 41 Seyon Street
Waltham, MA 02453
United States
781 250 0111
https://www.repligen.com
版塊: Healthcare
行業: Medical Instruments & Supplies
全職員工: 1,783
高階主管
| 名稱 | 頭銜 | 支付 | 行使價 | 出生年份 |
|---|---|---|---|---|
| Mr. Anthony J. Hunt | CEO & Director | 885k | 無 | 1964 |
| Mr. Olivier Loeillot | President & Chief Commercial Officer | 1.49M | 無 | 1970 |
| Mr. Jason K. Garland | CFO & Chief Compliance Officer | 282.99k | 無 | 1974 |
| Mr. James R. Bylund | Chief Operating Officer | 472.18k | 無 | 1964 |
| Ms. Christine Gebski | Senior Vice President of Filtration & Chromatography | 396.09k | 無 | 1968 |
| Mr. Ralf Kuriyel | Senior Vice President of Research & Development | 401.74k | 無 | 1958 |
| Mr. Keith Lee Robinson | Chief Information Officer | 無 | 無 | 無 |
| Ms. Sondra S. Newman | Global Head of Investor Relations | 無 | 無 | 無 |
| Ms. Kimberly A. Cornwell | General Counsel & Global Head of Legal | 無 | 無 | 無 |
| Dr. Jaime M. Humara Ph.D. | Senior Vice President of Global Marketing | 無 | 無 | 無 |
描述
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.
公司管治
截至 2024年5月1日 止，Repligen Corporation 的 ISS 管治質素評分為 2。 Pillar 分數正在審核中：8；董事會：3；股東權利：1；現金賠償：4。
